(Q40090604)

English

Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia

scientific article published on 21 August 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

invasive ductal carcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal adenocarcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pancreatic ductal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Lee KM

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Cao D

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Itami A

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Pour PM

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hruban RH

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Maitra A

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Ouellette MM

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

21 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

539-546

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Genetic progression in the pancreatic ducts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Docetaxel in the management of advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Combination gemcitabine and docetaxel therapy in advanced adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Promotion of microtubule assembly in vitro by taxol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Taxol stabilizes microtubules in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Microtubule-targeted anticancer agents and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Immortalization with telomerase of the Nestin-positive cells of the human pancreas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Mechanisms of Taxol resistance related to microtubules.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Class III β‐tubulin in human development and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Mechanisms of taxotere-related drug resistance in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02792.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2007.02792.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40090604&oldid=1885066760"